The influence of gender and sex steroid hormones on the plasma binding of propranolol enantiomers

1. Plasma binding of tritium‐labelled racemic propranolol (P) was measured by equilibrium dialysis. The unbound enantiomers were separated by h.p.l.c. after chiral derivatization. The binding of (‐)‐P was higher than that of (+)‐P. 2. Contrary to previous suggestions, a sex difference in the plasma...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of clinical pharmacology 1994-01, Vol.37 (1), p.21-25
Hauptverfasser: Walle, UK, Fagan, TC, Topmiller, MJ, Conradi, EC, Walle, T
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 25
container_issue 1
container_start_page 21
container_title British journal of clinical pharmacology
container_volume 37
creator Walle, UK
Fagan, TC
Topmiller, MJ
Conradi, EC
Walle, T
description 1. Plasma binding of tritium‐labelled racemic propranolol (P) was measured by equilibrium dialysis. The unbound enantiomers were separated by h.p.l.c. after chiral derivatization. The binding of (‐)‐P was higher than that of (+)‐P. 2. Contrary to previous suggestions, a sex difference in the plasma binding of the P enantiomers (9 young women, 12 young men) was not observed. The unbound percentage of (‐)‐P was 9.2 +/‐ 1.8 (mean +/‐ s.d.) in women vs 9.1 +/‐ 1.7 in men; for (+)‐ P it was 10.8 +/‐ 1.8 vs 10.8 +/‐ 2.1. 3. In the nine women, the binding did not change with fluctuating plasma oestradiol concentrations during the menstrual cycle. Testosterone cypionate doubled the circulating concentrations of testosterone in eight men but had no effect on P binding. 4. Ethinyl oestradiol (50 micrograms day‐1) alone or together with norethindrone (OCD) in eight of the women produced an increase in the unbound percentage of both (‐)‐P (11.4 +/‐ 2.6 vs 9.5 +/‐ 1.6 for control; P < 0.001) and (+)‐P (13.2 +/‐ 2.5 vs 11.2 +/‐ 1.5 for control; P < 0.001). This was due to a decrease in the plasma concentrations of alpha 1‐acid glycoprotein from 0.54 +/‐ 0.11 mg ml‐1 in control to 0.37 +/‐ 0.08 mg ml‐1 (P < 0.001) during ethinyl oestradiol treatment. 5. Enantioselectivity in the unbound fraction of P increased with increasing total binding from a (‐)/(+)‐ratio of 0.93 at 84% binding to a (‐)/(+)‐ratio of 0.78 at 94% binding (P < 0.001).
doi_str_mv 10.1111/j.1365-2125.1994.tb04233.x
format Article
fullrecord <record><control><sourceid>wiley_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1364704</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BCP4233</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5063-a746c61ad9b59d7acda0f12154663cad73b8429cb26e448581b141e2e78902313</originalsourceid><addsrcrecordid>eNqVkFuL1DAUx4Mo67j6EYQgvrbm5NbWB0WH9QIL-rA-hzRJZzK0SUm6OvvtN2WGQR89Lznwv5zwQ-gNkBrKvDvUwKSoKFBRQ9fxeukJp4zVxydoc5Geog1hRFaCCniOXuR8IAQYSHGFrlrgLQW-Qfpu77APw3jvgnE4DnjngnUJ62BxdkecF5eit3gf0xSDyzgGvJTMPOo8adz7YH3YrcE5xTnpEMc4Yhd0WHycXMov0bNBj9m9Or_X6NeXm7vtt-r2x9fv20-3lRFEsko3XBoJ2na96GyjjdVkAAqCS8mMtg3rW04701PpOG9FCz1wcNQ1bUcoA3aNPpx65_t-cta4sCQ9qjn5SacHFbVX_yrB79Uu_lYFGG8ILwXvTwUmxZyTGy5ZIGrlrg6rV6gVrlq5qzN3dSzh139fv0TPoIv-9qzrbPQ4FFDG54uNdbRA6Irt48n2x4_u4T8-oD5vf64bewQwp6Go</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The influence of gender and sex steroid hormones on the plasma binding of propranolol enantiomers</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Walle, UK ; Fagan, TC ; Topmiller, MJ ; Conradi, EC ; Walle, T</creator><creatorcontrib>Walle, UK ; Fagan, TC ; Topmiller, MJ ; Conradi, EC ; Walle, T</creatorcontrib><description>1. Plasma binding of tritium‐labelled racemic propranolol (P) was measured by equilibrium dialysis. The unbound enantiomers were separated by h.p.l.c. after chiral derivatization. The binding of (‐)‐P was higher than that of (+)‐P. 2. Contrary to previous suggestions, a sex difference in the plasma binding of the P enantiomers (9 young women, 12 young men) was not observed. The unbound percentage of (‐)‐P was 9.2 +/‐ 1.8 (mean +/‐ s.d.) in women vs 9.1 +/‐ 1.7 in men; for (+)‐ P it was 10.8 +/‐ 1.8 vs 10.8 +/‐ 2.1. 3. In the nine women, the binding did not change with fluctuating plasma oestradiol concentrations during the menstrual cycle. Testosterone cypionate doubled the circulating concentrations of testosterone in eight men but had no effect on P binding. 4. Ethinyl oestradiol (50 micrograms day‐1) alone or together with norethindrone (OCD) in eight of the women produced an increase in the unbound percentage of both (‐)‐P (11.4 +/‐ 2.6 vs 9.5 +/‐ 1.6 for control; P &lt; 0.001) and (+)‐P (13.2 +/‐ 2.5 vs 11.2 +/‐ 1.5 for control; P &lt; 0.001). This was due to a decrease in the plasma concentrations of alpha 1‐acid glycoprotein from 0.54 +/‐ 0.11 mg ml‐1 in control to 0.37 +/‐ 0.08 mg ml‐1 (P &lt; 0.001) during ethinyl oestradiol treatment. 5. Enantioselectivity in the unbound fraction of P increased with increasing total binding from a (‐)/(+)‐ratio of 0.93 at 84% binding to a (‐)/(+)‐ratio of 0.78 at 94% binding (P &lt; 0.001).</description><identifier>ISSN: 0306-5251</identifier><identifier>EISSN: 1365-2125</identifier><identifier>DOI: 10.1111/j.1365-2125.1994.tb04233.x</identifier><identifier>PMID: 8148214</identifier><identifier>CODEN: BCPHBM</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adult ; Biological and medical sciences ; Catecholaminergic system ; Chromatography, High Pressure Liquid ; Drug Synergism ; Estradiol - blood ; Estradiol - pharmacology ; Ethinyl Estradiol - pharmacology ; Female ; Humans ; Male ; Medical sciences ; Menstrual Cycle ; Middle Aged ; Neuropharmacology ; Neurotransmitters. Neurotransmission. Receptors ; Norethindrone - pharmacology ; Pharmacology. Drug treatments ; Propranolol - blood ; Propranolol - pharmacokinetics ; Sex Characteristics ; Stereoisomerism ; Testosterone - analogs &amp; derivatives ; Testosterone - blood ; Testosterone - pharmacology</subject><ispartof>British journal of clinical pharmacology, 1994-01, Vol.37 (1), p.21-25</ispartof><rights>1994 The British Pharmacological Society</rights><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5063-a746c61ad9b59d7acda0f12154663cad73b8429cb26e448581b141e2e78902313</citedby><cites>FETCH-LOGICAL-c5063-a746c61ad9b59d7acda0f12154663cad73b8429cb26e448581b141e2e78902313</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,309,310,314,776,780,785,786,881,4035,4036,23910,23911,25119,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3920639$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8148214$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Walle, UK</creatorcontrib><creatorcontrib>Fagan, TC</creatorcontrib><creatorcontrib>Topmiller, MJ</creatorcontrib><creatorcontrib>Conradi, EC</creatorcontrib><creatorcontrib>Walle, T</creatorcontrib><title>The influence of gender and sex steroid hormones on the plasma binding of propranolol enantiomers</title><title>British journal of clinical pharmacology</title><addtitle>Br J Clin Pharmacol</addtitle><description>1. Plasma binding of tritium‐labelled racemic propranolol (P) was measured by equilibrium dialysis. The unbound enantiomers were separated by h.p.l.c. after chiral derivatization. The binding of (‐)‐P was higher than that of (+)‐P. 2. Contrary to previous suggestions, a sex difference in the plasma binding of the P enantiomers (9 young women, 12 young men) was not observed. The unbound percentage of (‐)‐P was 9.2 +/‐ 1.8 (mean +/‐ s.d.) in women vs 9.1 +/‐ 1.7 in men; for (+)‐ P it was 10.8 +/‐ 1.8 vs 10.8 +/‐ 2.1. 3. In the nine women, the binding did not change with fluctuating plasma oestradiol concentrations during the menstrual cycle. Testosterone cypionate doubled the circulating concentrations of testosterone in eight men but had no effect on P binding. 4. Ethinyl oestradiol (50 micrograms day‐1) alone or together with norethindrone (OCD) in eight of the women produced an increase in the unbound percentage of both (‐)‐P (11.4 +/‐ 2.6 vs 9.5 +/‐ 1.6 for control; P &lt; 0.001) and (+)‐P (13.2 +/‐ 2.5 vs 11.2 +/‐ 1.5 for control; P &lt; 0.001). This was due to a decrease in the plasma concentrations of alpha 1‐acid glycoprotein from 0.54 +/‐ 0.11 mg ml‐1 in control to 0.37 +/‐ 0.08 mg ml‐1 (P &lt; 0.001) during ethinyl oestradiol treatment. 5. Enantioselectivity in the unbound fraction of P increased with increasing total binding from a (‐)/(+)‐ratio of 0.93 at 84% binding to a (‐)/(+)‐ratio of 0.78 at 94% binding (P &lt; 0.001).</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Catecholaminergic system</subject><subject>Chromatography, High Pressure Liquid</subject><subject>Drug Synergism</subject><subject>Estradiol - blood</subject><subject>Estradiol - pharmacology</subject><subject>Ethinyl Estradiol - pharmacology</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Menstrual Cycle</subject><subject>Middle Aged</subject><subject>Neuropharmacology</subject><subject>Neurotransmitters. Neurotransmission. Receptors</subject><subject>Norethindrone - pharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Propranolol - blood</subject><subject>Propranolol - pharmacokinetics</subject><subject>Sex Characteristics</subject><subject>Stereoisomerism</subject><subject>Testosterone - analogs &amp; derivatives</subject><subject>Testosterone - blood</subject><subject>Testosterone - pharmacology</subject><issn>0306-5251</issn><issn>1365-2125</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkFuL1DAUx4Mo67j6EYQgvrbm5NbWB0WH9QIL-rA-hzRJZzK0SUm6OvvtN2WGQR89Lznwv5zwQ-gNkBrKvDvUwKSoKFBRQ9fxeukJp4zVxydoc5Geog1hRFaCCniOXuR8IAQYSHGFrlrgLQW-Qfpu77APw3jvgnE4DnjngnUJ62BxdkecF5eit3gf0xSDyzgGvJTMPOo8adz7YH3YrcE5xTnpEMc4Yhd0WHycXMov0bNBj9m9Or_X6NeXm7vtt-r2x9fv20-3lRFEsko3XBoJ2na96GyjjdVkAAqCS8mMtg3rW04701PpOG9FCz1wcNQ1bUcoA3aNPpx65_t-cta4sCQ9qjn5SacHFbVX_yrB79Uu_lYFGG8ILwXvTwUmxZyTGy5ZIGrlrg6rV6gVrlq5qzN3dSzh139fv0TPoIv-9qzrbPQ4FFDG54uNdbRA6Irt48n2x4_u4T8-oD5vf64bewQwp6Go</recordid><startdate>199401</startdate><enddate>199401</enddate><creator>Walle, UK</creator><creator>Fagan, TC</creator><creator>Topmiller, MJ</creator><creator>Conradi, EC</creator><creator>Walle, T</creator><general>Blackwell Publishing Ltd</general><general>Blackwell Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>199401</creationdate><title>The influence of gender and sex steroid hormones on the plasma binding of propranolol enantiomers</title><author>Walle, UK ; Fagan, TC ; Topmiller, MJ ; Conradi, EC ; Walle, T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5063-a746c61ad9b59d7acda0f12154663cad73b8429cb26e448581b141e2e78902313</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Catecholaminergic system</topic><topic>Chromatography, High Pressure Liquid</topic><topic>Drug Synergism</topic><topic>Estradiol - blood</topic><topic>Estradiol - pharmacology</topic><topic>Ethinyl Estradiol - pharmacology</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Menstrual Cycle</topic><topic>Middle Aged</topic><topic>Neuropharmacology</topic><topic>Neurotransmitters. Neurotransmission. Receptors</topic><topic>Norethindrone - pharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Propranolol - blood</topic><topic>Propranolol - pharmacokinetics</topic><topic>Sex Characteristics</topic><topic>Stereoisomerism</topic><topic>Testosterone - analogs &amp; derivatives</topic><topic>Testosterone - blood</topic><topic>Testosterone - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Walle, UK</creatorcontrib><creatorcontrib>Fagan, TC</creatorcontrib><creatorcontrib>Topmiller, MJ</creatorcontrib><creatorcontrib>Conradi, EC</creatorcontrib><creatorcontrib>Walle, T</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of clinical pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Walle, UK</au><au>Fagan, TC</au><au>Topmiller, MJ</au><au>Conradi, EC</au><au>Walle, T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The influence of gender and sex steroid hormones on the plasma binding of propranolol enantiomers</atitle><jtitle>British journal of clinical pharmacology</jtitle><addtitle>Br J Clin Pharmacol</addtitle><date>1994-01</date><risdate>1994</risdate><volume>37</volume><issue>1</issue><spage>21</spage><epage>25</epage><pages>21-25</pages><issn>0306-5251</issn><eissn>1365-2125</eissn><coden>BCPHBM</coden><abstract>1. Plasma binding of tritium‐labelled racemic propranolol (P) was measured by equilibrium dialysis. The unbound enantiomers were separated by h.p.l.c. after chiral derivatization. The binding of (‐)‐P was higher than that of (+)‐P. 2. Contrary to previous suggestions, a sex difference in the plasma binding of the P enantiomers (9 young women, 12 young men) was not observed. The unbound percentage of (‐)‐P was 9.2 +/‐ 1.8 (mean +/‐ s.d.) in women vs 9.1 +/‐ 1.7 in men; for (+)‐ P it was 10.8 +/‐ 1.8 vs 10.8 +/‐ 2.1. 3. In the nine women, the binding did not change with fluctuating plasma oestradiol concentrations during the menstrual cycle. Testosterone cypionate doubled the circulating concentrations of testosterone in eight men but had no effect on P binding. 4. Ethinyl oestradiol (50 micrograms day‐1) alone or together with norethindrone (OCD) in eight of the women produced an increase in the unbound percentage of both (‐)‐P (11.4 +/‐ 2.6 vs 9.5 +/‐ 1.6 for control; P &lt; 0.001) and (+)‐P (13.2 +/‐ 2.5 vs 11.2 +/‐ 1.5 for control; P &lt; 0.001). This was due to a decrease in the plasma concentrations of alpha 1‐acid glycoprotein from 0.54 +/‐ 0.11 mg ml‐1 in control to 0.37 +/‐ 0.08 mg ml‐1 (P &lt; 0.001) during ethinyl oestradiol treatment. 5. Enantioselectivity in the unbound fraction of P increased with increasing total binding from a (‐)/(+)‐ratio of 0.93 at 84% binding to a (‐)/(+)‐ratio of 0.78 at 94% binding (P &lt; 0.001).</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>8148214</pmid><doi>10.1111/j.1365-2125.1994.tb04233.x</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0306-5251
ispartof British journal of clinical pharmacology, 1994-01, Vol.37 (1), p.21-25
issn 0306-5251
1365-2125
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1364704
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Adult
Biological and medical sciences
Catecholaminergic system
Chromatography, High Pressure Liquid
Drug Synergism
Estradiol - blood
Estradiol - pharmacology
Ethinyl Estradiol - pharmacology
Female
Humans
Male
Medical sciences
Menstrual Cycle
Middle Aged
Neuropharmacology
Neurotransmitters. Neurotransmission. Receptors
Norethindrone - pharmacology
Pharmacology. Drug treatments
Propranolol - blood
Propranolol - pharmacokinetics
Sex Characteristics
Stereoisomerism
Testosterone - analogs & derivatives
Testosterone - blood
Testosterone - pharmacology
title The influence of gender and sex steroid hormones on the plasma binding of propranolol enantiomers
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T04%3A15%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20influence%20of%20gender%20and%20sex%20steroid%20hormones%20on%20the%20plasma%20binding%20of%20propranolol%20enantiomers&rft.jtitle=British%20journal%20of%20clinical%20pharmacology&rft.au=Walle,%20UK&rft.date=1994-01&rft.volume=37&rft.issue=1&rft.spage=21&rft.epage=25&rft.pages=21-25&rft.issn=0306-5251&rft.eissn=1365-2125&rft.coden=BCPHBM&rft_id=info:doi/10.1111/j.1365-2125.1994.tb04233.x&rft_dat=%3Cwiley_pubme%3EBCP4233%3C/wiley_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/8148214&rfr_iscdi=true